📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Safety and tolerability of conserved region vaccines vectored by plasmid DNA, simian adenovirus and modified vaccinia virus ankara administered to human immunodeficiency virus type 1-uninfected adults in a randomized, single-blind phase I trial. (2014)

First Author: Hayton EJ

Attributed to: Developmental Clinical Studies - Depletion of serum amyloid P component to enhance the immune response to DNA vaccination funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pone.0101591

PubMed Identifier: 25007091

Publication URI: http://europepmc.org/abstract/MED/25007091

Type: Journal Article/Review

Volume: 9

Parent Publication: PloS one

Issue: 7

ISSN: 1932-6203